Gastroenterology Research and Practice / 2020 / Article / Tab 4

Research Article

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Table 4

Multivariate analysis of clinical parameters independently associated with significant histological abnormalities.

Patient characteristicsClinical parametersOR (95% CI) value

Presence of hepatic steatosis5.481 (2.992-10.041)0.001
Presence of significant hepatic steatosis (≥S2)Baseline AST0.978 (0.959-0.998)0.029
Baseline UA1.006 (1.000-1.012)0.040
Presence of significant fibrosis (≥F2)Baseline AST1.006 (1.000-1.012)0.038

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.